Stichting European Myeloma Network
Clinical trials sponsored by Stichting European Myeloma Network, explained in plain language.
-
New combo shows promise in slowing multiple myeloma progression
Disease control CompletedThis study tested whether adding daratumumab to the usual two-drug therapy (pomalidomide and dexamethasone) helps people with relapsed or refractory multiple myeloma live longer without their cancer getting worse. 304 adults who had already tried at least one prior treatment took…
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Jun 17, 2026 07:40 UTC
-
Promising drug targets rare protein disease in phase 2 trial
Disease control CompletedThis study tested a drug called belantamab mafodotin in 35 people with AL amyloidosis, a rare disease where abnormal proteins build up in organs. All participants had already received at least one prior treatment. The goal was to see how many patients achieved a significant reduc…
Phase: PHASE2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC